Market Risers: Lighthouse Group plc, GlaxoSmithKline plc, Admiral Group plc, Aviva plc, Direct Line Insurance Group PLC & Legal & General Group Plc

Lighthouse Group Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Shares of Lighthouse Group plc company symbol: LON:LGT has stepped up 4.68% or 1.1 points throughout today’s trading session so far. Buyers have remained optimistic during this period. Range high for the period so far is 24.7 while the low for the session was 23.7. The volume total for shares traded up to this point was 128,003 with the daily average at 89,309. The stock 52 week high is 41 which comes in at 17.5 points difference from the previous days close and the 52 week low at 17 which is a variance of 6.5 points. Lighthouse Group plc has a 20 SMA of 22.97 with a 50 day MA at 25.36. The current market cap is £31.41m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Lighthouse Group plc being recorded at Wednesday, January 9, 2019 at 11:46:32 AM GMT with the stock price trading at 24.6 GBX.

 

Shares of GlaxoSmithKline plc company symbol: LON:GSK has moved up 2.16% or 32.84 points during today’s session so far. Traders have remained optimistic while the stock has been in play. Range high for the period so far is 1554.6 and a low of 1527.4. The amount of shares exchanged has so far reached 2,200,984 with the daily average number around 13,247,915. A 52 week high for the stock is 1648.8 equating to 129.6 points in difference to the previous days close of business and a 52 week low sitting at 1179.39 which is a difference of 339.81 points. GlaxoSmithKline plc has a 20 day moving average of 1511.09 and now its 50 day SMA of 1541.52. Market capitalisation for the company is £77,050.43m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for GlaxoSmithKline plc being recorded at Wednesday, January 9, 2019 at 12:02:29 PM GMT with the stock price trading at 1552.04 GBX.

 

Shares of Admiral Group plc with company EPIC: LON:ADM has risen 2.38% or 48 points during the course of today’s session so far. Investors have stayed positive throughout the session. The high for the period has peaked at 2074 and hitting a low of 2029. Volume total for shares traded during this period was 101,073 with the daily average traded share volume around 748,080. The 52 week high is 2138 which is 118 points difference from the previous days close and putting the 52 week low at 1794.5 a difference of some 225.5 points. Admiral Group plc has a 20 day moving average of 2006.68 and now its 50 day MA at 2032.65. Market capitalisation is now £6,007.60m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Admiral Group plc being recorded at Wednesday, January 9, 2019 at 12:02:11 PM GMT with the stock price trading at 2068 GBX.

 

Shares of Aviva plc EPIC code: LON:AV has risen 1.49% or 5.79 points in today’s trading session so far. Buyers have so far held a positive outlook while the stock has been in play. The periods high has reached 396.2 meanwhile the session low reached 386.8. The volume total for shares traded up to this point was 3,399,269 with the average number of shares traded daily being 12,508,438. The 52 week high is 554.6 amounting to 166.7 points difference from the previous days close and the 52 week low at 361.8 which is a difference of 26.1 points. Aviva plc now has a 20 SMA of 378.52 and now its 50 day moving average now of 404.21. The current market capitalisation is £15,363.10m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Aviva plc being recorded at Wednesday, January 9, 2019 at 12:02:38 PM GMT with the stock price trading at 393.69 GBX.

 

Shares of Direct Line Insurance Group PLC with company EPIC: LON:DLG has gained 2.01% or 6.5 points in today’s trading session so far. Buyers are a positive bunch throughout the session. Range high for the period has seen 330.4 dipping to 323.3. The number of shares traded by this point in time totalled 546,981 with the daily average number around 6,850,901. A 52 week share price high is 397 which comes in at 73.9 points difference from the previous days close and putting the 52 week low at 300.66 is a variance of 22.44 points. Direct Line Insurance Group PLC now has a 20 moving average of 315.98 and now its 50 day moving average of 321.78. The market capitalisation is now £4,532.00m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for Direct Line Insurance Group PLC being recorded at Wednesday, January 9, 2019 at 12:02:20 PM GMT with the stock price trading at 329.6 GBX.

 

The trading price for Legal & General Group Plc ticker lookup code: LON:LGEN has moved up 1.16% or 2.78 points in today’s trading session so far. Buyers have remained positive during the session. The period high has peaked at 242.1 and hitting a low of 235.9. The total volume traded so far comes to 4,857,120 with the average number of shares traded daily being 16,867,224. The 52 week high is 289.45 which is 50.45 points difference from the previous close and the 52 week low at 221.8 which is a variance of 17.2 points. Legal & General Group Plc now has a 20 SMA at 232.09 and now the 50 day moving average at 243.9. The market capitalisation is now £14,412.02m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for Legal & General Group Plc being recorded at Wednesday, January 9, 2019 at 12:02:39 PM GMT with the stock price trading at 241.78 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Aviva plc announces a strategic acquisition of Direct Line, enhancing its growth and performance. The deal offers benefits for both customers and shareholders.
    GSK reports success in phase III trial of Zejula and Jemperli for advanced ovarian cancer, achieving significant progression-free survival improvement.
    GSK's Jemperli receives FDA Breakthrough Therapy Designation for treating locally advanced dMMR/MSI-H rectal cancer, expediting crucial development.

      Search

      Search